Mechanisms of Cannabinoid Inhibition of GABA(A) Synaptic Transmission in the Hippocampus

Overview

Journal J Neurosci

Specialty Neurology

Date 2000 Mar 24

PMID 10729327

Citations 144

Authors

A F Hoffman

C R Lupica

Affiliations

Soon will be listed here.

Abstract

The localization of cannabinoid (CB) receptors to GABAergic interneurons in the hippocampus indicates that CBs may modulate GABAergic function and thereby mediate some of the disruptive effects of marijuana on spatial memory and sensory processing. To investigate the possible mechanisms through which CB receptors may modulate GABAergic neurotransmission in the hippocampus, whole-cell voltage-clamp recordings were performed on CA1 pyramidal neurons in rat brain slices. Stimulus-evoked GABA(A) receptor-mediated IPSCs were reduced in a concentration-dependent manner by the CB receptor agonist WIN 55,212-2 (EC(50) of 138 nM). This effect was blocked by the CB1 receptor antagonist SR141716A (1 microM) but not by the opioid antagonist naloxone. In contrast, evoked GABA(B)-mediated IPSCs were insensitive to the CB agonist. WIN 55,212-2 also reduced the frequency of spontaneous, action potential-dependent IPSCs (sIPSCs), without altering action potential-independent miniature IPSCs (mIPSCs), measured while sodium channels were blocked by tetrodotoxin (TTX). Blockade of voltage-dependent calcium channels (VDCCs) by cadmium also eliminated the effect of WIN 55,212-2 on sIPSCs. Depolarization of inhibitory terminals with elevated extracellular potassium caused a large increase in the frequency of mIPSCs that was inhibited by both cadmium and WIN 55,212-2. The presynaptic effect of WIN 55,212-2 was also investigated using the potassium channel blockers barium and 4-aminopyridine. Neither of these agents significantly altered the effect of WIN 55,212-2 on evoked IPSCs. Together, these data suggest that presynaptic CB1 receptors reduce GABA(A)- but not GABA(B)-mediated synaptic inhibition of CA1 pyramidal neurons by inhibiting VDCCs located on inhibitory nerve terminals.

Citing Articles

Daily oscillation of the excitation/inhibition ratio is disrupted in two mouse models of autism.

Bridi M, Luo N, Kim G, Menarchek B, Lee R, Rodriguez B iScience. 2025; 28(1):111494.

PMID: 39850357 PMC: 11754079. DOI: 10.1016/j.isci.2024.111494.

A Comprehensive Review and Update on Cannabis Hyperemesis Syndrome.

Loganathan P, Gajendran M, Goyal H Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598458 PMC: 11597608. DOI: 10.3390/ph17111549.

Neuroinflammation in the Central Nervous System: Exploring the Evolving Influence of Endocannabinoid System.

Rathod S, Agrawal Y, Nakhate K, Meeran M, Ojha S, Goyal S Biomedicines. 2023; 11(10).

PMID: 37893016 PMC: 10604915. DOI: 10.3390/biomedicines11102642.

Subtle Structural Modification of a Synthetic Cannabinoid Receptor Agonist Drastically Increases its Efficacy at the CB1 Receptor.

Yano H, Chitsazi R, Lucaj C, Tran P, Hoffman A, Baumann M ACS Chem Neurosci. 2023; 14(21):3928-3940.

PMID: 37847546 PMC: 10623572. DOI: 10.1021/acschemneuro.3c00530.

The electrophysiological and behavioral evaluation of the peptide hemopressin and cannabinoid CB1 receptor agonist and antagonist in pentylenetetrazol model of epilepsy in rats.

Al-Kaleel A, Aygun H, Al-Gailani L, Kabak Y, Inal S, Ayyildiz M Pflugers Arch. 2023; 475(6):719-730.

PMID: 37100982 DOI: 10.1007/s00424-023-02814-y.

References

Twitchell W, Brown S, Mackie K . Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol. 1997; 78(1):43-50. DOI: 10.1152/jn.1997.78.1.43. View

Gifford A, Ashby Jr C . Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. J Pharmacol Exp Ther. 1996; 277(3):1431-6. View

Knowles W . Normal anatomy and neurophysiology of the hippocampal formation. J Clin Neurophysiol. 1992; 9(2):252-63. View

Collins D, Pertwee R, Davies S . Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice. Br J Pharmacol. 1995; 115(6):869-70. PMC: 1909030. DOI: 10.1111/j.1476-5381.1995.tb15889.x. View

Ling D, Benardo L . Properties of isolated GABAB-mediated inhibitory postsynaptic currents in hippocampal pyramidal cells. Neuroscience. 1994; 63(4):937-44. DOI: 10.1016/0306-4522(94)90561-4. View

Miller L, Branconnier R . Cannabis: effects on memory and the cholinergic limbic system. Psychol Bull. 1983; 93(3):441-56. View

Miller K, HOFFER A, Svoboda K, Lupica C . Cholecystokinin increases GABA release by inhibiting a resting K+ conductance in hippocampal interneurons. J Neurosci. 1997; 17(13):4994-5003. PMC: 6573316. View

Deadwyler S, Hampson R, Mu J, Whyte A, Childers S . Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J Pharmacol Exp Ther. 1995; 273(2):734-43. View

Doze V, Cohen G, Madison D . Calcium channel involvement in GABAB receptor-mediated inhibition of GABA release in area CA1 of the rat hippocampus. J Neurophysiol. 1995; 74(1):43-53. DOI: 10.1152/jn.1995.74.1.43. View

10.

Chan P, Chan S, Yung W . Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonist. Neuroreport. 1998; 9(4):671-5. DOI: 10.1097/00001756-199803090-00020. View

11.

TSOU K, Brown S, Mackie K, Walker J . Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience. 1998; 83(2):393-411. DOI: 10.1016/s0306-4522(97)00436-3. View

12.

Essman E . Marijuana intoxication in rats: interruption of recent memory and effect on brain concentration of delta 9-tetrahydrocannabinol. Psychol Rep. 1984; 55(2):563-7. DOI: 10.2466/pr0.1984.55.2.563. View

13.

Pertwee R . Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther. 1997; 74(2):129-80. DOI: 10.1016/s0163-7258(97)82001-3. View

14.

Shen M, Thayer S . The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons. Brain Res. 1998; 783(1):77-84. DOI: 10.1016/s0006-8993(97)01195-5. View

15.

Herkenham M, Lynn A, Little M, Johnson M, Melvin L, De Costa B . Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A. 1990; 87(5):1932-6. PMC: 53598. DOI: 10.1073/pnas.87.5.1932. View

16.

Okeefe J . Hippocampus, theta, and spatial memory. Curr Opin Neurobiol. 1993; 3(6):917-24. DOI: 10.1016/0959-4388(93)90163-s. View

17.

Szabo B, Dorner L, Pfreundtner C, Norenberg W, Starke K . Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience. 1998; 85(2):395-403. DOI: 10.1016/s0306-4522(97)00597-6. View

18.

Alger B, Nicoll R . Pharmacological evidence for two kinds of GABA receptor on rat hippocampal pyramidal cells studied in vitro. J Physiol. 1982; 328:125-41. PMC: 1225650. DOI: 10.1113/jphysiol.1982.sp014256. View

19.

Levenes C, Daniel H, Soubrie P, Crepel F . Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells. J Physiol. 1998; 510 ( Pt 3):867-79. PMC: 2231086. DOI: 10.1111/j.1469-7793.1998.867bj.x. View

20.

Cohen G, Doze V, Madison D . Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons. Neuron. 1992; 9(2):325-35. DOI: 10.1016/0896-6273(92)90171-9. View